The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in ...

Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S ...

After 31 years as a publicly-traded Massachusetts company, Aspen Technology has ceased to exist as an independent firm.

LONDON (Reuters) - Canada's Barrick Gold must pay British dealmaker Ian Hannam's firm $2 million plus expenses for his work ...

The C$15 billion Whitecap-Veren merger creates the 7th-largest Canadian oil & gas producer. Read why SPGYF and VRN stocks are ...

PGA Tour players are about to lose what's left of their tolerance when it comes to the merger with LIV Golf, according to ...

ProfitSolv, a startup that offers billing and payments services, is looking for a new owner with first round bids due next ...

FOX 13's Jennifer Kveglis reports on the possibility that USF Sarasota Manatee and New College of Florida will be absorbed ...

Ansys shares offer an 8% upside with a Synopsys merger, creating a $28B leader. Read more about ANSS stock here.

After a contentious meeting Pender County leaders moved forward with an initiative to take over a private emergency services ...

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...

Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.